Hopewell Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$7.8M
- Investors
-
6
Hopewell Therapeutics General Information
Description
Developer of novel biodegradable lipid nanoparticles designed to give technology and services to bring genomic medicines to patients. The company's technology is developed through novel synthetic lipid-based nanoparticles for nucleic acid delivery for gene therapy and gene editing, enabling healthcare professionals to better immunotherapy, gene therapy, and gene editing.
Contact Information
Website
www.hopewell-tx.comCorporate Office
- 216 West Cummings Park
- Woburn, MA 01801
- United States
Corporate Office
- 216 West Cummings Park
- Woburn, MA 01801
- United States
Hopewell Therapeutics Timeline
Hopewell Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 17-May-2024 | $7.8M | Completed | Generating Revenue | ||
| 2. Seed Round | 02-Feb-2022 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2018 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Hopewell Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Hopewell Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Hopewell Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 5Y Capital | Venture Capital | Minority | ||
| BOPU Capital | Venture Capital | Minority | ||
| Hike Capital | Venture Capital | Minority | ||
| Mass Ave Capital | Venture Capital | Minority | ||
| IMO Ventures | Venture Capital | Minority |
Hopewell Therapeutics FAQs
-
When was Hopewell Therapeutics founded?
Hopewell Therapeutics was founded in 2018.
-
Where is Hopewell Therapeutics headquartered?
Hopewell Therapeutics is headquartered in Woburn, MA.
-
What is the size of Hopewell Therapeutics?
Hopewell Therapeutics has 13 total employees.
-
What industry is Hopewell Therapeutics in?
Hopewell Therapeutics’s primary industry is Drug Delivery.
-
Is Hopewell Therapeutics a private or public company?
Hopewell Therapeutics is a Private company.
-
What is Hopewell Therapeutics’s current revenue?
The current revenue for Hopewell Therapeutics is .
-
How much funding has Hopewell Therapeutics raised over time?
Hopewell Therapeutics has raised $23.4M.
-
Who are Hopewell Therapeutics’s investors?
5Y Capital, BOPU Capital, Hike Capital, Mass Ave Capital, and IMO Ventures are 5 of 6 investors who have invested in Hopewell Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
